Gastrointestinal disorders, Guidance

Applied filters

Care Setting (3)
- Neonates (2)
- Primary Care and PCNs (1)
Guidance (116)
- Administering (2)
- Advanced therapy medicinal products (4)
- Dosing (2)
- Formulation (3)
- Medicines Safety (1)
- Prescribing (1)
- Safety in Breastfeeding (92)
- Safety in Pregnancy (4)
- Stability in dosette boxes (60)
- Stability outside the fridge (8)
- Swallowing difficulties (1)
- Switching (1)
Medicine (107)
- Adalimumab (2)
- Adrenaline (1)
- Aluminium hydroxide (2)
- Aluminium hydroxide + Magnesium trisilicate (1)
- Alverine (1)
- Amisulpride (1)
- Aprepitant (2)
- Arachis oil (1)
- Atropine (1)
- Azathioprine (1)
- Balsalazide (2)
- Beclometasone (3)
- Beclometasone + Formoterol (1)
- Benzyl benzoate (1)
- Betahistine (2)
- Bisacodyl (1)
- Budesonide (3)
- Budesonide + Formoterol (1)
- Buprenorphine (1)
- Carbamazepine (1)
- Chlorpromazine (2)
- Cholic acid (1)
- Ciclosporin (2)
- Cimetidine (2)
- Cinchocaine (1)
- Cinchocaine + Hydrocortisone (1)
- Cinnarizine (2)
- Clonidine (1)
- Co-danthramer (1)
- Co-magaldrox (2)
- Co-phenotrope (1)
- Codeine (2)
- Colestyramine (1)
- Cyclizine (2)
- Dantrolene (1)
- Darvadstrocel (1)
- Dexamethasone (1)
- Dicycloverine (1)
- Diltiazem (2)
- Docusate (1)
- Domperidone (2)
- Doxycycline (1)
- Doxylamine + Pyridoxine (2)
- Erythromycin (1)
- Esomeprazole (3)
- Famotidine (2)
- Fentanyl (1)
- Fluticasone (1)
- Fluticasone + Formoterol (1)
- Fluticasone + Salmeterol (1)
- Fosaprepitant (2)
- Glycerol (1)
- Golimumab (2)
- Granisetron (1)
- Hydrocortisone (1)
- Hydrocortisone + Pramocaine (1)
- Hydrotalcite (2)
- Hyoscine butylbromide (1)
- Hyoscine hydrobromide (2)
- Infliximab (1)
- Kaolin (1)
- Ketoprofen + Omeprazole (1)
- Lactulose (1)
- Lansoprazole (3)
- Liquid paraffin (1)
- Liraglutide (1)
- Lithium (1)
- Lithium carbonate (1)
- Loperamide (2)
- Lubiprostone (1)
- Macrogol 3350 (1)
- Magnesium carbonate (2)
- Magnesium sulfate (1)
- Magnesium trisilicate (2)
- Mebendazole (1)
- Mebeverine (1)
- Mercaptopurine (1)
- Mesalazine (3)
- Methotrexate (1)
- Methylcellulose (1)
- Methylphenidate (1)
- Metoclopramide (2)
- Misoprostol (2)
- Morphine (1)
- Mycophenolate mofetil (1)
- Nabilone (2)
- Netupitant + Palonosetron (2)
- Nifedipine (1)
- Nizatidine (2)
- Obeticholic acid (1)
- Olsalazine (1)
- Omeprazole (3)
- Ondansetron (2)
- Oxycodone (1)
- Palonosetron (2)
- Pancreatin (1)
- Pantoprazole (2)
- Peppermint oil (1)
- Perphenazine (2)
- Phenobarbital (1)
- Phenytoin (1)
- Prednisolone (1)
- Primidone (1)
- Prochlorperazine (2)
- Promethazine hydrochloride (2)
- Promethazine teoclate (1)
- Propantheline (1)
- Prucalopride (1)
- Rabeprazole (2)
- Ranitidine (2)
- Salmeterol (1)
- Senna (1)
- Simeticone (1)
- Sodium acid phosphate + Sodium phosphate (1)
- Sodium alginate + Magnesium alginate (2)
- Sodium bicarbonate (3)
- Sodium chloride (3)
- Sodium citrate (1)
- Sodium picosulfate (1)
- Sucralfate (2)
- Sulfasalazine (2)
- Tacrolimus (1)
- Teduglutide (1)
- Tiotropium (1)
- Tramadol (1)
- Trastuzumab (1)
- Trastuzumab emtansine (1)
- Trifluoperazine (2)
- Tripotassium dicitratobismuthate (2)
- Ursodeoxycholic acid (1)
- Ustekinumab (2)
- Vedolizumab (2)
Medicines planning (37)
- New Medicines (23)
  - CCG commissioned new medicines (15)
  - NHS England commissioned new medicines (8)
  - Pre-registration new medicines (UK/EU) (2)
- Patent expiries (27)
Specialty (116)
- Allergy and immunology (4)
- Anaesthesia and pain (6)
- Cancers (3)
- Cardiovascular system disorders (3)
- Diabetes (1)
- Ear, nose and throat disorders (5)
- Endocrine system disorders (2)
- Eyes and vision (5)
- Gastrointestinal disorders (116)
- Haematological disorders (2)
- Infection and infectious diseases (1)
- Mental health and illness (20)
- Musculo-skeletal disorders (8)
- Neurological disorders (2)
- Nutritional and metabolic disorders (2)
- Obstetrics and gynaecology (3)
- Renal and urologic disorders (5)
- Respiratory disorders (6)
- Skin disorders (4)
- Transplantation (1)

ICEF15

Factors to consider when using medicines following bariatric surgery (gastric bypass)

31 March 2022Guidance on the physiological changes after bariatric surgery that can affect the absorption of medicines and supplements.

The effect of bariatric surgery (gastric bypass) on certain medicines

31 March 2022There is some evidence on the effect of bariatric surgery (gastric bypass) on specific medicines which may inform prescribing decisions for those patients.

Example medicines to prescribe by brand name in primary care

27 March 2022Prescribe certain medicines by brand to ensure supply of the same product. Examples are grouped by therapeutic area. The list of products is not exhaustive.

High dose loperamide use in high stoma output or short bowel syndrome

11 January 2022This guidance explores the dosing and monitoring advice when using high dose loperamide to reduce high stoma output or in short bowel syndrome in adults.

Nausea and Vomiting: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of nausea and vomiting in pregnancy

Constipation: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of constipation in pregnancy

Heartburn and Dyspepsia: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of heartburn and dyspepsia in pregnancy

Haemorrhoids: treatment during pregnancy

6 January 2022Signposting evidence-based information on the treatment of haemorrhoids in pregnancy

Sodium content of medicines for indigestion and gastric disorders

26 October 2021List of effervescent, soluble, dispersible and other preparations for treating indigestion and gastric disorders that could contain high levels of sodium.

SPS - Specialist Pharmacy Service

NHS